Ambu A/SAmbu A/SAmbu A/S

Ambu A/S

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.40 B‬USD
0.21USD
‪35.07 M‬USD
‪804.52 M‬USD
‪140.81 M‬
Beta (1Y)
0.37
Employees (FY)
‪5.2 K‬
Change (1Y)
+580 +12.56%
Revenue / Employee (1Y)
‪154.83 K‬USD
Net income / Employee (1Y)
‪6.75 K‬USD

About Ambu A/S Class B


CEO
Britt Meelby Jensen
Website
Headquarters
Ballerup
Founded
1956
ISIN
DK0060946788
FIGI
BBG00GD70Z06
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Check out other big names from the same industry as AMBFF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.07%
Market value
‪8.77 M‬
USD
XACTC25
XACT OMXC25 ESG (UCITS ETF)
Weight
1.14%
Market value
‪8.58 M‬
USD
VSS
Vanguard FTSE All-World ex-US Small-Cap ETF
Weight
0.06%
Market value
‪7.33 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.01%
Market value
‪4.90 M‬
USD
SCHC
Schwab International Small-Cap Equity ETF
Weight
0.08%
Market value
‪3.71 M‬
USD
DFIS
Dimensional International Small Cap ETF
Weight
0.09%
Market value
‪3.70 M‬
USD
DFIC
Dimensional International Core Equity 2 ETF
Weight
0.02%
Market value
‪2.67 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of AMBFF is 14.56 USD — it has decreased by −5.48% in the past 24 hours. Watch Ambu A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ambu A/S stocks are traded under the ticker AMBFF.
AMBFF stock has fallen by −5.52% compared to the previous week, the month change is a −5.52% fall, over the last year Ambu A/S has showed a −26.85% decrease.
We've gathered analysts' opinions on Ambu A/S future price: according to them, AMBFF price has a max estimate of 23.33 USD and a min estimate of 13.82 USD. Watch AMBFF chart and read a more detailed Ambu A/S stock forecast: see what analysts think of Ambu A/S and suggest that you do with its stocks.
AMBFF reached its all-time high on Nov 7, 2017 with the price of 90.37 USD, and its all-time low was 9.26 USD and was reached on Oct 11, 2022. View more price dynamics on AMBFF chart.
See other stocks reaching their highest and lowest prices.
AMBFF stock is 5.80% volatile and has beta coefficient of 0.37. Track Ambu A/S stock price on the chart and check out the list of the most volatile stocks — is Ambu A/S there?
Today Ambu A/S has the market capitalization of ‪3.42 B‬, it has increased by 3.80% over the last week.
Yes, you can track Ambu A/S financials in yearly and quarterly reports right on TradingView.
Ambu A/S is going to release the next earnings report on Feb 4, 2026. Keep track of upcoming events with our Earnings Calendar.
AMBFF earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.08 USD resulting in a −18.02% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about Ambu A/S earnings.
Ambu A/S revenue for the last quarter amounts to ‪229.87 M‬ USD, despite the estimated figure of ‪236.00 M‬ USD. In the next quarter, revenue is expected to reach ‪241.32 M‬ USD.
AMBFF net income for the last quarter is ‪19.38 M‬ USD, while the quarter before that showed ‪27.24 M‬ USD of net income which accounts for −28.87% change. Track more Ambu A/S financial stats to get the full picture.
Yes, AMBFF dividends are paid annually. The last dividend per share was 0.05 USD. As of today, Dividend Yield (TTM)% is 0.46%. Tracking Ambu A/S dividends might help you take more informed decisions.
Ambu A/S dividend yield was 0.29% in 2024, and payout ratio reached 43.06%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 7, 2025, the company has ‪5.2 K‬ employees. See our rating of the largest employees — is Ambu A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ambu A/S EBITDA is ‪181.79 M‬ USD, and current EBITDA margin is 18.66%. See more stats in Ambu A/S financial statements.
Like other stocks, AMBFF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ambu A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ambu A/S technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ambu A/S stock shows the sell signal. See more of Ambu A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.